Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market.
Halia Therapeutics Published in Journey of Drug Targeting
The Company filed a substantial non-provisional PCT patent application seeking worldwide protection for its novel cancer treatment platform
Epic Ventures Gains $200M Fresh Capital
Canyon Labs Opens Expanded Facility
Intermountain Health Announces New Children’s Health President and Expands Leadership Role for Hospital President to Build on Legacy of Pediatric Excellence
Bioseeker™ is the AI Discovery Engine Powering Seek Labs’ Mission to Outpace Disease with Faster, Smarter Global Health Solutions
Thin-wall design with superior insertion and unique sheath-securement solution to support successful radial access procedures and may aid in reducing arterial spasm and occlusion
James A. Bowman brings decades of experience launching disruptive surgical innovations.
Quansys Biosciences Launches Q-View™ Imager Plus: Delivering Reproducible, high-impact ELISA Data with Ease
Improving Women’s Health: MobileODT Joins Liger Medical
Utah Investment Firm Expands to Deliver Flexible Capital to Transformative Healthcare Companies